LeanbrowLeanbrow
  • Home
  • Entertainment
  • Hollywood
  • Fashion
  • Tv Serials
Reading: Shares of this pharma company rose 33% from the bottom, likely to cross 3950 anytime now.
Share
Aa
LeanbrowLeanbrow
Aa
  • Business
  • Entertainment
  • Fashion
Search
  • Home
  • Entertainment
  • Hollywood
  • Fashion
  • Tv Serials
Follow US
  • Home
  • About Us
  • Contact Us
  • RSS
  • Privacy Policy
  • Disclaimer
© 2023 Leanbrow. All Rights Reserved.
Leanbrow > News > Business > Shares of this pharma company rose 33% from the bottom, likely to cross 3950 anytime now.
Business

Shares of this pharma company rose 33% from the bottom, likely to cross 3950 anytime now.

Shreya Bhanshali
Last updated: 2023/06/30 at 5:09 PM
Shreya Bhanshali
Share
3 Min Read
Shares of this pharma company rose 33% from the bottom, - Leanbrow
SHARE


Divis Laboratories Share: There is a bullish atmosphere in the shares of Divis Laboratories, a company in the pharmaceutical sector. The stock is up nearly 33 per cent from its fifty-two week low and has further signs of upside. Experts believe that this stock can go up to 3950 in the coming days. On 14 March 2023, shares of Divis Labs hit a fifty-two week low. 2730 and closed at 3584 on 27th June. Today this stock has closed at 3586.

Divis Labs hit a 52-week high of Rs. 3973. From January 2023 till now, this share has increased by only 6 percent. But the best performance has been seen since the end of March. The stock was at its fifty two week high on August 10, 2022. But its all time high was recorded on 18 October 2021 when its price became 5425.

Experts believe that short term traders can consider Divis Labs shares as the stock is likely to move towards 3950 levels in three to four weeks. The stock takes support near 3000 level which is the breakout zone for it.

Even in the post-Covid period, Divis Laboratories was one of the best performing stocks in the pharma sector. Before Kovid this stock was running at 550 but after Kovid it reached 5425. That is, the capital of the investors had increased more than 10 times. Once the level of 5425 was made, there was a correction of about 49 percent in this stock and in March 2023, the shares of Divis Labs made a double bottom of 2750 and 2730.

Looking at the current chart pattern of Divis Labs, it seems that if this stock sustains 3290 levels then this stock can easily move towards 3950 levels. Especially the view of the last three months is spectacular. Kiran Jani, head of technical research at Jainum Broking, said that the bullish pattern will continue in this stock. The daily Relative Strength Index for the shares of Divis Laboratories is 59.6. An RSI below 30 is considered oversold and above 70 is considered overbought. Divi’s Lab stock moved above 5, 10, 20, 30, 50 and 100 days DMA.

Share this Article
Facebook Twitter Whatsapp Whatsapp Copy Link
Share
Previous Article Rukhsar Rehman: Rift in actress Rukhsar Rehman’s second marriage, going - Leanbrow Rukhsar Rehman: Rift in actress Rukhsar Rehman’s second marriage, going to get divorce after 13 years
Next Article Mandira Bedi: On the second death anniversary of her husband - Leanbrow Mandira Bedi: On the second death anniversary of her husband Raj Kaushal, Mandira Bedi got emotional and said something very touching.
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

Facebook Like
Twitter Follow
Pinterest Pin
Instagram Follow

Latest News

The teaser of ‘The Battle Story of Somnath’ is out, - Leanbrow
The teaser of ‘The Battle Story of Somnath’ is out, it will be released in 12 languages
Entertainment July 16, 2023
Bawaal Trailer: The trailer of Varun-Jahnavi’s film ‘Bawal’ has arrived, the film is about the ‘war’ of human mind.
Entertainment July 9, 2023
Titan shares soar 3% to new high: What’s driving the - Leanbrow
Titan shares soar 3% to new high: What’s driving the rally? Still buy or not?
Business July 9, 2023
Kajol got stuck for making controversial remarks on the leaders - Leanbrow
Kajol got stuck for making controversial remarks on the leaders of the country, reacted on Twitter
Entertainment July 9, 2023
LeanbrowLeanbrow
Follow US

© 2023 Leanbrow. All Rights Reserved.

  • Home
  • About Us
  • Contact Us
  • RSS
  • Privacy Policy
  • Disclaimer
Welcome Back!

Sign in to your account

Lost your password?